Mutation detection analysis of a region of 16S-like ribosomal RNA gene of <it>Entamoeba histolytica</it>, <it>Entamoeba dispar </it>and <it>Entamoeba moshkovskii</it>

1471-2334-8-131 1471-2334 Research article Mutation detection analysis of a region of 16S-like ribosomal RNA gene of <it>Entamoeba histolytica</it>, <it>Entamoeba dispar </it>and <it>Entamoeba moshkovskii</it> Parija Chandra Subhash subhashparija@yahoo.co.in Khairnar Krishna kskhairnar@yahoo.co.in

Department of Microbiology, Jawaharlal Institute of Postgraduate, Medical Education and Research, Puducherry, 605006, India

BMC Infectious Diseases 1471-2334 2008 8 1 131 http://www.biomedcentral.com/1471-2334/8/131 18822136 10.1186/1471-2334-8-131 29 4 2008 26 9 2008 26 9 2008 2008 Parija and Khairnar; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

The level of intra-species genetic variation in Entamoeba histolytica, Entamoeba dispar and Entamoeba moshkovskii populations in a localized geographic area, like Puducherry, India, remains unknown.

Methods

In the present study the existence of genetic variation in the nested multiplex polymerase chain reaction (NM-PCR) amplified region of the 16S-like ribosomal RNA genes of E. histolytica, E. dispar and E. moshkovskii was investigated by riboprinting and single strand conformation polymorphism (SSCP) analysis.

Results

We found that 70 stool specimens were positive for E. histolytica, 171 stool specimens were positive for E. dispar, and 37 stool specimens were positive for E. moshkovskii by NM-PCR. Ninety liver abscess pus specimens, 21 urine specimens, and 8 saliva specimens were positive for E. histolytica by NM-PCR. Riboprinting analysis detected a mutation in the PCR product of only one E. histolytica isolate from a stool specimen. However, SSCP analysis detected mutations in the PCR products of five E. histolytica isolates and three E. moshkovskii isolates from stool specimens, and one E. histolytica isolate from a saliva specimen. The mutations detected by riboprinting and SSCP analysis were confirmed by sequencing. All the nucleotide sequences showing mutations in this study have already been deposited into the NCBI GenBank database under accession numbers [GenBank: EF682200 to GenBank: EF682208].

Conclusion

The present study has revealed the subsistence of mutations in the ribosomal RNA genes of E. histolytica and E. moshkovskii, which points towards the existence of intra-species genetic variation in E. histolytica and E. moshkovskii isolates infecting humans.

Background

The protozoan parasite Entamoeba histolytica is estimated to infect 50 million people and cause 40,000 to 100,000 deaths annually, making it the second largest cause of mortality from infection with parasitic protozoa after malaria 1.

Although the first description of amoebiasis was more than a century ago 2, there is still uncertainty as to why symptoms of the disease appear only in 10% of those infected with E. histolytica while majority remains asymptomatic 3. There have been several suggestions regarding the factors that may contribute to the outcome of amoebic infection in a susceptible host, which include a range of virulence levels among the E. histolytica strains and variability in host immunity against amoebic invasion. While the variability of human immunity against amoebic infection is not well understood, the existence of genetic variation in E. histolytica has been studied in depth recently 4567891011121314151617. These studies have identified genetic variation in protein-coding sequences of E. histolytica, such as those for the serine-rich E. histolytica protein 101112131415 and chitinase 81112, as well as non-protein-coding regions such as the ribosomal RNA (rRNA) genes 457 and loci 1–2 and 5–6 11121617. In addition, the existence of genetic variation in non-protein-coding loci 1–2 and 5–6 18, as well as protein-coding chitinase gene of E. dispar has been reported recently 19.

These genetic variation studies appear to be promising in investigating the molecular epidemiology of amoebiasis. The existence of significant genetic variation among E. histolytica isolates collected from a wide geographical range, including Mexico, Bangladesh, India, Venezuela, South Africa, the Philippines, and Georgia, has already been demonstrated 891314. However, whether intra-species genetic variation also exists in E. histolytica, Entamoeba dispar and Entamoeba moshkovskii from a population in a restricted geographic area like Puducherry, India, still remains unknown.

The rRNAs, especially the 16S rRNA, have been widely used for studying genetic variation because of their conservative nature and universal distribution 20. In the present study an attempt has been made to study genetic variation in regions of the 16S-like rRNA gene of E. histolytica, E. dispar and E. moshkovskii using riboprinting and single strand conformation polymorphism (SSCP) analysis followed by confirmation by nucleotide sequencing.

Methods

Sample details

The study was conducted at the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) hospital, Puducherry, India, during the period from July 2004 to July 2006. Informed consent was obtained from the patients. The study was approved by the Institute Human Ethics Committee (JIPMER, Puducherry, India).

Stool

Fresh unpreserved stool samples from 202 patients with complaints of gastrointestinal discomfort and positive for E. histolytica, E. dispar, or E. moshkovskii by microscopy or culture were collected in sterile capped containers and stored at -20°C until used.

Liver abscess pus

The liver abscess pus aspiration was performed only for clinical purposes, as judged necessary by the clinicians for the patient care and not for the purpose of this study. The liver abscess pus was obtained under ultrasound guidance from 112 amoebic liver abscess (ALA) patients and stored at -20°C in a sterile container until used.

Urine

A urine specimen was collected from 53 ALA patients. Ten millilitres of urine were collected in a sterile container using aseptic techniques and stored at -20°C until used.

Saliva

A saliva specimen was collected from 28 ALA patients. Five millilitres of saliva were collected in a sterile container using aseptic techniques and stored at 4°C until used.

Entamoeba 16S-like rRNA gene amplification by nested multiplex polymerase chain reaction (NM-PCR)

Extraction of Entamoeba genomic DNA

The extraction of Entamoeba genomic DNA from stool, liver abscess pus, urine, and saliva specimens was performed as per the method described previously 212223.

Primers used

Based on the sequences of the 16S-like rRNA gene of E. histolytica, E. dispar and E. moshkovskii, nested sets of primers (designated E-1/E-2, EH-1/EH-2, ED-1/ED-2 and Mos-1/Mos-2) were used as described previously 21.

Standard strains

E. histolytica HM-1:IMSS, E. dispar SAW760, and E. moshkovskii Laredo were the standard strains used as positive controls in the present study. The lyophilized DNA of these strains was generously gifted by Dr. C. Graham Clark from the London School of Hygiene and Tropical Medicine, London, UK.

NM-PCR

Stool PCR

The PCR mix composition was as described previously 21.

Liver abscess pus PCR

For genus specific and species specific PCR, the reaction volume of 25 μl was comprised of 2.5 μl of 10× PCR buffer (Biogene), 2.0 μl of 25 mM MgCl₂(Bangalore genei), 0.75 μl of deoxyribo-nucleotide triphosphate mix (10 mM each dNTP, Biogene), 0.3 μl (5 IU/μl) of Taq polymerase (Biogene), 0.25 μM primers (IDT) and 2.0 μl of template DNA. Amplification was performed in an Eppendorf Thermal cycler [Master cycler gradient].

Urine PCR

The PCR mix composition was the same as described above for liver abscess pus PCR, except that 1.0 μl of 25 mM MgCl₂and 2.5 μl of template DNA was added.

Saliva PCR

The PCR mix composition was the same as described above for liver abscess pus PCR, except that 1.0 μl of 25 mM MgCl₂was added.

The PCR cycle conditions were as described previously 21.

Mutation detection by riboprinting

Restriction enzymes

Restriction enzymes were used to generate comparative riboprints. The restriction enzymes were selected for the 439 bp, 553 bp and 174 bp PCR product of 16S-like rRNA gene of E. histolytica, E. moshkovskii and E. dispar, respectively, using the online software "NEB cutter V2.0" http://tools.neb.com/NEBcutter2/index.php. The restriction enzymes used are shown in Table 1.

Table 1

Restriction enzymes used for riboprinting analysis of partial regions of the 16S-like rRNA genes of E. histolytica, E. dispar and E. moshkovskii

E. histolytica (439 bp)

E. moshkovskii (553 bp)

E. dispar (174 bp)

Xba I

Taq I

Dde I

Hpy188 III

Mse I

Mfe I

Sau96 I

N1aIV

Hinf I

Mse I

Sau96 I

Restriction enzyme digestion

In a 25 μl reaction mix, 15 μl of nested PCR product was digested with 2.5 units of each restriction enzyme in separate 0.2 ml tubes. The incubation period was for 16 hrs at 37°C except for the restriction enzymes Taq I and Mse I where the incubation temperature was 65°C.

Agarose gel electrophoresis

Twenty microlitres of the restriction enzyme digested PCR product was separated by electrophoresis through a 2.5% agarose gel (Agarose Low EEO, Bangalore genie products, Bangalore, India) containing ethidium bromide in 0.5 × Tris-acetate-EDTA (TAE) buffer at 120 V for 45 min and was visualized under UV light.

Mutation detection by SSCP

Preparation of the SSCP gel

In the present study 6% and 9% SSCP gels were used. Six percent SSCP gels were used for mutation detection in the 439 bp and 553 bp PCR products of E. histolytica and E. moshkovskii, respectively. A nine percent SSCP gel was used for mutation detection in the 174 bp PCR product of E. dispar.

Preparation of samples for SSCP electrophoresis

Two microlitres of the nested PCR product was diluted into 20 μl formamide dye mix in a 0.2 ml microfuge tube. A similar aliquot was diluted into 20 μl of gel loading dye. The formamide containing sample was boiled for 6 minutes in a water bath, and then the tube was plunged directly into ice for 10 minutes.

Separation of DNA fragments by SSCP gel electrophoresis

The wells of the polyacrylamide gel were washed with 1× TAE electrophoresis buffer. 4 μl of denatured DNA (DNA boiled with formamide dye mix) was loaded into the well of polyacrylamide gel. Two microlitres of non-denatured DNA (DNA with gel loading dye) was loaded into another well. Approximately 6–7 V/cm (~110 V [and 16 mA] for 18 × 14-cm gel) was applied to the gel for 16 hrs at a temperature of 20–25°C in an air conditioned room. On completion of the electrophoresis, the gel was silver stained.

Silver staining of SSCP gel

Silver staining for nucleic acid was performed as per the method described previously 20. The gel was documented using a densitometer (Biorad) and the results analyzed using "Quantity One" software (Biorad). For long term storage the gel was kept in 10% glycerol.

Nucleotide sequencing

PCR products of 16S-like rRNA genes of E. histolytica, E. dispar and E. moshkovskii showing mutation by riboprinting or SSCP analysis, were sequenced on a ABI3730XL sequencer (Macrogen, Seoul, South Korea) using species specific primers. The nucleotide sequences were edited with reference to chromatographs using Chromas (Version 1.62) software and aligned using BioEdit (version 7).

Nucleotide sequence accession numbers

The nucleotide sequences showing mutations in this study have been deposited into the NCBI GenBank database under accession numbers EF682200–EF682208] (Table 2).

Table 2

E. histolytica and E. moshkovskii isolates obtained from clinical specimens of patients attending JIPMER hospital, Puducherry, showing mutation by PCR-SSCP analysis

S. No

Entamoeba species

Clinical specimen

GenBank submission [GenBank accession number]

E. histolytica

Stool

Entamoeba histolytica isolate 1 [GenBank: EF682200]

E. histolytica

Stool

Entamoeba histolytica isolate 2 [GenBank: EF682201]

E. histolytica

Stool

Entamoeba histolytica isolate 3 [GenBank: EF682202]

E. histolytica

Stool

Entamoeba histolytica isolate 4 [GenBank: EF682203]

E. histolytica

Stool

Entamoeba histolytica isolate 5 [GenBank: EF682204]

E. moshkovskii

Stool

Entamoeba moshkovskii isolate 6 [GenBank: EF682206]

E. moshkovskii

Stool

Entamoeba moshkovskii isolate 7 [GenBank: EF682207]

E. moshkovskii

Stool

Entamoeba moshkovskii isolate 8 [GenBank: EF682208]

E. histolytica

Saliva

Entamoeba histolytica isolate 1 [GenBank: EF682205]

Results

Entamoeba 16S-like r RNA gene amplification by NM-PCR

Stool PCR

Seventy stool specimens were positive for the 439 bp PCR product of E. histolytica, 171 stool specimens were positive for the 174 bp PCR product of E. dispar, and 37 stool specimens were positive for the 553 bp PCR product of E. moshkovskii.

Liver abscess pus PCR

Ninety liver abscess pus specimens were positive for the 439 bp PCR product of E. histolytica.

Urine PCR

Twenty one urine specimens were positive for the 439 bp PCR product of E. histolytica.

Saliva PCR

Eight saliva specimens were positive for the 439 bp PCR product of E. histolytica.

Mutation detection by riboprinting

No intra-species variation in restriction fragment length polymorphism (RFLP) patterns for any restriction enzyme was observed, except for the N1aIV RFLP pattern of the E. histolytica specific 439 bp PCR product from one stool specimen (Stool- 5).

Normal RFLP digestion pattern for the 174 bp, 439 bp, and 553 bp PCR product of E. dispar, E. histolytica and E. moshkovskii respectively with various restriction enzymes are shown in figure 1.

Figure 1

Normal RFLP digestion pattern for 174 bp, 439 bp, and 553 bp PCR products of E. dispar, E. histolytica and E. moshkovskii respectively with various restriction enzymes

Normal RFLP digestion pattern for 174 bp, 439 bp, and 553 bp PCR products of E. dispar, E. histolytica and E. moshkovskii respectively with various restriction enzymes. Lane-1 to 4 normal riboprints for E. dispar (ED); Lane-5 to 11 normal riboprints for E. histolytica (EH); Lane-12 to 19 normal riboprints for E. moshkovskii (EM).

Mutation detection by SSCP

Five out of 70 E. histolytica specific 439 bp PCR products from stool specimens, one out of 8 E. histolytica specific 439 bp PCR products from saliva specimens, and three out of 37 E. moshkovskii specific 553 bp PCR products from stool specimens showed an altered SSCP profile (i.e. a mobility shift in the acrylamide gel) suggestive of a mutation (Figure 2 and Figure 3).

Figure 2

SSCP analysis showing altered profile (mobility shift) for the 439 bp PCR product of E. histolytica. Lane-1 is for E. histolytica standard DNA (EH-Std)

SSCP analysis showing altered profile (mobility shift) for the 439 bp PCR product of E. histolytica. Lane-1 is for E. histolytica standard DNA (EH-Std); Lane-2, 3, 4, 5, and 6 are for E. histolytica DNA from stool specimens showing an altered profile; Lane-7 is for E. histolytica DNA from a saliva specimen showing an altered profile.

Figure 3

SSCP analysis showing altered profile (mobility shift) for the 553 bp PCR product of E. moshkovskii. Lane-1 is for E. moshkovskii standard DNA (EM-Std)

SSCP analysis showing altered profile (mobility shift) for the 553 bp PCR product of E. moshkovskii. Lane-1 is for E. moshkovskii standard DNA (EM-Std); Lane-2, 3, and 4 are for E. moshkovskii DNA from stool specimens showing an altered profile.

None of the 171 E. dispar specific 174 bp PCR products from stool specimens, 90 E. histolytica specific 439 bp PCR products from liver abscess pus specimens, or 21 E. histolytica specific 439 bp PCR products from urine specimens showed an altered SSCP profile suggestive of a mutation.

The E. histolytica and E. moshkovskii isolates showing mutations by PCR-SSCP analysis are summarized in table 2.

Nucleotide sequencing

All four E. histolytica specific 439 bp PCR products from stool specimens (Stool- 1, 2, 3, and 4) showing a mutation by SSCP analysis and the E. histolytica specific 439 bp PCR product from stool specimen showing mutation by both SSCP and riboprinting analysis (Stool- 5), were confirmed by nucleotide sequencing. The multiple sequence alignment of these sequencing results and the standard strain E. histolytica HM-1:IMSS is depicted in figure 4. The comparative electropherogram showing the mutant (Stool- 1, 2, 3, 4, and 5) and normal control (E. histolytica HM-1:IMSS) 16S-like rRNA genes is shown in figure 5.

Figure 4

Multiple sequence alignment of E. histolytica specific 439 bp PCR products from clinical specimens (Stool-1 to 5 and Saliva-1) and the standard strain E. histolytica HM-1:IMSS (EH-Std)

Multiple sequence alignment of E. histolytica specific 439 bp PCR products from clinical specimens (Stool-1 to 5 and Saliva-1) and the standard strain E. histolytica HM-1:IMSS (EH-Std). The sequence variations are highlighted in red.

Figure 5

Electropherogram showing the mutant (Stool-1 to 5) and normal control E. histolytica HM-1:IMSS (EH-Std) 16S-like rRNA genes

Electropherogram showing the mutant (Stool-1 to 5) and normal control E. histolytica HM-1:IMSS (EH-Std) 16S-like rRNA genes. Chromatogram showing the sequence variation is indicated by an arrow. The sequencing revealed substitution of A by G and substitution of A by T (A), insertion of T (B), insertion of T (C), insertion of T (D), and substitution of G by A and insertion of T (E).

All three E. moshkovskii PCR products showing mutation by SSCP analysis (Stool- 6, 7, and 8) were confirmed by nucleotide sequencing. The multiple sequence alignment of these sequences and the standard strain E. moshkovskii Laredo is depicted in figure 6. The comparative electropherogram showing the mutant (Stool- 6, 7, and 8) and normal control (E. moshkovskii Laredo) 16S-like rRNA genes is shown in figure 7.

Figure 6

Multiple sequence alignment of the E. moshkovskii specific 553 bp PCR products from stool specimens (Stool-6 to 8) and the standard strain E. moshkovskii Laredo (EM-Std)

Multiple sequence alignment of the E. moshkovskii specific 553 bp PCR products from stool specimens (Stool-6 to 8) and the standard strain E. moshkovskii Laredo (EM-Std). The sequence variations are highlighted in red.

Figure 7

Electropherogram showing the mutant (Stool-6 to 8) and normal control E. moshkovskii Laredo (EM-Std) 16S-like rRNA genes

Electropherogram showing the mutant (Stool-6 to 8) and normal control E. moshkovskii Laredo (EM-Std) 16S-like rRNA genes. Chromatogram showing the sequence variation is indicated by an arrow. The sequencing revealed substitution of A by G (A), substitution of A by T and substitution of A by T (B), and substitution of A by C (C)

The one E. histolytica PCR product from a saliva specimen showing mutation by SSCP analysis was also confirmed by sequencing. The multiple sequence alignment of the results from this saliva specimen and the standard strain E. histolytica HM-1:IMSS is depicted in figure 4. The comparative electropherogram showing the mutant (Saliva-1) and normal control (E. histolytica HM-1:IMSS) is shown in figure 8.

Figure 8

Electropherogram showing the mutant (Saliva-1) and normal control E. histolytica HM-1:IMSS (EH-Std) 16S-like rRNA genes

Electropherogram showing the mutant (Saliva-1) and normal control E. histolytica HM-1:IMSS (EH-Std) 16S-like rRNA genes. Chromatogram showing the sequence variation is indicated by an arrow. The sequencing revealed substitution of C by A (A)

Discussion

Mutations and other polymorphisms in genes, gene systems, or whole genomes may play an important role in Entamobea. DNA sequencing is considered the gold standard for identifying such mutations. Nevertheless, DNA sequencing method is cumbersome and costly when large numbers of samples need to be rapidly analyzed. The method, therefore, is not always suitable for use in epidemiological studies.

In the present study, PCR products of 16S-like rRNA gene of E. histolytica, E. moshkovskii and E. dispar were subjected to screening for mutation by riboprinting and SSCP analysis. These products were of a relatively small sizes, 553 bp for E. moshkovskii, 439 bp for E. histolytica and 174 bp for E. dispar, and were found to be particularly suitable for SSCP analysis.

Riboprinting analysis detected a mutation in only one of the E. histolytica samples, from a stool specimen (Stool- 5); the alteration in the RFLP pattern (i.e. the PCR product remained undigested) was due to substitution of G by A in the recognition site of N1aIV. The inability of riboprinting to detect mutations in a majority of Entamoeba isolates is due to the limitation that RFLP detects mutation only when they occur in restriction endonuclease cut sites. However, SSCP analysis detected mutation in a total of five E. histolytica and three E. moshkovskii isolates from stool and one E. histolytica isolate from saliva. This may be attributed to the ability of SSCP, unlike RFLP, to detect any mutation in a DNA sequence. The SSCP analysis results that were suggestive of mutations were reproducible (i.e. SSCP analysis showed identical profiles in three separate experiments).

In this study none of the 171 E. dispar isolates showed characteristics suggestive of mutation by SSCP analysis, perhaps due to the screening of only a 174 bp region of the gene. The chances of finding a mutation in such a small region is less than in larger regions studied for the other two species.

Although it was observed that riboprinting was useful for screening a large number of samples, especially when looking for a specific single nucleotide polymorphism, the method has some inherent disadvantages. In this method, a large amount of amplicon (15 μl) is needed for digestion with each of several enzymes, and each clinical sample ends up being electrophoresed on several gels, making it a very laborious and time consuming procedure.

SSCP analysis, on the other hand, was found to be simple and convenient in the present study. The results were obtained from only 2 μl of PCR product on a single SSCP gel, which in the long run turned out to be much more economical. The total time needed for PCR-SSCP was less than 24 hours. The SSCP technique developed and evaluated in our laboratory provides us with a rapid tool for detecting mutations in Entamoeba. This method could conveniently supplement other methods of mutation detection analysis on large-scale. The limitation of SSCP, although minor, is that it detects the occurrence of single base mutations in a segment of DNA but does not give any information on the type or location of the base changes, which have to be confirmed by nucleotide sequencing.

In the present study, the results showed that SSCP analysis was able to detect even single nucleotide differences (Figure 5, Figure 7, and Figure 8). Nucleotide sequences were verified three times by sequencing of products of different PCR reaction from the same source of DNA to rule out any discrepancy due to sequencing errors. The sequencing analysis identified four new E. histolytica genotypes and three new E. moshkovskii genotypes (Figure 4 and Figure 6). Recently, a report from Bangladesh 16 studied clinical specimens using six tRNA-linked STR loci, and detected 85 genotypes in 111 unrelated samples. Another report from Bangladesh 15 also studied clinical samples but used a nested PCR-RFLP of the SREHP gene. Twenty five genotypes among 42 intestinal isolates and 9 genotypes among 12 ALA samples were found. Out of 9 genotypes from liver abscess samples, 8 were unique to the ALA samples investigated. In our study no unique genotypes among any of the liver abscess samples and urine samples from ALA cases were found, but out of 5 E. histolytica genotypes from stool samples 4 were unique to the stool samples investigated. In addition, our study also detected one unique E. histolytica genotype from a saliva sample from an ALA case and three new E. moshkovskii genotypes from stool samples. Clark and Diamond 6 combined results of both PCR-RFLP of SREHP and amplification of the SSG locus to report 16 different genotypes among 18 isolates of E. histolytica from varied geographical locations. Haghighi et al. 11 reported a total of 53 different genotypes among 63 isolates of E. histolytica, mostly from Japan and Thailand, using sequencing of four loci (two tRNA-linked STR loci, chitinase, and SREHP). The high level of diversity reported from different geographic locations suggest that the rapid generation of new Entamoeba variants is taking place. The occurrence of new E. histolytica and E. moshkovskii genotypes in the area of Puducherry, India, may be a unique finding and the close relationship of these genotypes with a recognized human pathogen like E. histolytica should prompt further studies.

In this study, the presence of mutations was explored in a region of 16S-like rRNA gene of E. histolytica, E. dispar and E. moshkovskii by applying riboprinting and SSCP analysis. Further studies are needed to extend mutation detection to the complete ribosomal RNA gene of these species, which will possibly reveal much more about genetic variation in Entamoeba.

Conclusion

The present study has revealed the subsistence of mutation in ribosomal RNA gene of E. histolytica and E. moshkovskii, which points towards the existence of intra-species genetic variation in E. histolytica and E. moshkovskii isolates infecting humans.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

SCP supervised and coordinated the study, and helped to draft the manuscript. KK carried out the experimental work, and drafted the manuscript.

Acknowledgements

We are grateful to Dr. C. Graham Clark from London School of Hygiene and Tropical Medicine for providing us with lyophilized DNA of standard cultures of E. histolytica HM-1:IMSS, E. dispar SAW760, and E. moshkovskii Laredo.

Amoebiasis World Health Organization Wkly Epidemiol Rec 1997 72 97 99 9100475 Massive development of amebas in the large intestine. Translation from the original in Russian, 1875 Lösch FA Am J Trop Med Hyg 1975 24 383 392 1098489 Amoebae: Intestinal Amoebae Pathogenic Free-living Amoebae Parija SC Text book of medical parasitology Chennai: All India Publishers & Distributors Parija SC 2006 29 64 Ribosomal RNA genes of 'pathogenic' and 'nonpathogenic' <it>Entamoeba histolytica </it>are distinct Clark CG Diamond LS Mol Biochem Parasitol 1991 49 297 302 10.1016/0166-6851(91)90073-F 1685555 <it>Entamoeba histolytica </it>extrachromosomal circular ribosomal DNA: analysis of clonal variation in a hypervariable region Bhattacharya S Bhattacharya A Diamond LS Exp Parasitol 1992 74 200 204 10.1016/0014-4894(92)90047-E 1346767 <it>Entamoeba histolytica</it>: a method for isolate identification Clark CG Diamond LS Exp Parasitol 1993 77 450 455 10.1006/expr.1993.1105 8253158 Analysis of a polymorphic locus present upstream of rDNA transcription units in the extrachromosomal circle of <it>Entamoeba histolytica</it> Sehgal D Bhattacharya A Bhattacharya S Mol Biochem Parasitol 1993 62 129 130 10.1016/0166-6851(93)90187-3 8114815 Molecular epidemiology of <it>Entamoeba </it>spp.: evidence of a bottleneck (demographic sweep) and transcontinental spread of diploid parasites Ghosh S Frisardi M Ramirez-Avila L J Clin Microbiol 2000 38 3815 3821 87481 11015408 Isolation and characterization of polymorphic DNA from <it>Entamoeba histolytica</it> Zaki M Clark CG J Clin Microbiol 2001 39 897 905 87847 11230401 10.1128/JCM.39.3.897-905.2001 Isolation and characterization of genomic clones encoding a serine-rich <it>Entamoeba histolytica </it>protein Li E Kunz-Jenkins C Stanley SL Jr Mol Biochem Parasitol 1992 50 355 357 10.1016/0166-6851(92)90234-B 1741023 Geographic diversity among genotypes of <it>Entamoeba histolytica </it>field isolates Haghighi A Kobayashi S Takeuchi T Thammapalerd N Nozaki T J Clin Microbiol 2003 41 3748 56 179867 12904386 10.1128/JCM.41.8.3748-3756.2003 Remarkable genetic polymorphism among <it>Entamoeba histolytica </it>isolates from a limited geographic area Haghighi A Kobayashi S Takeuchi T Masuda G Nozaki T J Clin Microbiol 2002 40 4081 90 139687 12409379 10.1128/JCM.40.11.4081-4090.2002 <it>Entamoeba histolytica</it>: the serine-rich gene polymorphism-based genetic variability of clinical isolates from Georgia Simonishvili S Tsanava S Sanadze K Chlikadze R Miskalishvili A Lomkatsi N Imnadze P Petri WA Jr Trapaidze N Exp Parasitol 2005 110 313 7 10.1016/j.exppara.2005.02.015 15955330 Prevalence and genetic diversity of <it>Entamoeba histolytica </it>in an institution for the mentally retarded in the Philippines Rivera WL Santos SR Kanbara H Parasitol Res 2006 98 106 10 10.1007/s00436-005-0024-8 16284779 <it>Entamoeba histolytica</it>: genetic diversity of clinical isolates from Bangladesh as demonstrated by polymorphisms in the serine-rich gene Ayeh-Kumi PF Ali IM Lockhart LA Gilchrist CA Petri WA Jr Haque R Exp Parasitol 2001 99 80 8 10.1006/expr.2001.4652 11748961 Evidence for a link between parasite genotype and outcome of infection with <it>Entamoeba histolytica</it> Ali IK Mondal U Roy S Haque R Petri WA Jr Clark CG J Clin Microbiol 2007 45 285 9 1829016 17122021 10.1128/JCM.01335-06 Isolation and characterization of polymorphic DNA from <it>Entamoeba histolytica</it> Zaki M Clark CG J Clin Microbiol 2001 39 897 905 87847 11230401 10.1128/JCM.39.3.897-905.2001 Genetic characterization of <it>Entamoeba dispar </it>isolates in Northeast Brazil Pinheiro SM Maciel RF Morais MA Jr Aca IS Carvalho LB Jr Coimbra MR Acta Trop 2005 94 35 40 10.1016/j.actatropica.2005.01.012 15777694 <it>E. dispar </it>strain: analysis of polymorphism as a tool for study of geographic distribution Ramos F García G Valadez A Morán P González E Gómez A Melendro EI Valenzuela O Ximénez C Mol Biochem Parasitol 2005 141 175 7 10.1016/j.molbiopara.2005.02.010 15850700 Sambrook J Russell DW Molecular Cloning, A Laboratory Manual New York: Cold Spring Harbor Laboratory Press 2000 A novel nested multiplex polymerase chain reaction (PCR) assay for differential detection of <it>Entamoeba histolytica</it>, <it>E. moshkovskii </it>and <it>E. dispar </it>DNA in stool samples Khairnar K Parija SC BMC Microbiol 2007 24 47 10.1186/1471-2180-7-47 Detection of excretory <it>Entamoeba histolytica </it>DNA in the urine, and detection of <it>E. histolytica </it>DNA and lectin antigen in the liver abscess pus for the diagnosis of amoebic liver abscess Parija SC Khairnar K BMC Microbiol 2007 18 41 10.1186/1471-2180-7-41 Detection of <it>Entamoeba histolytica </it>DNA in the saliva of amoebic liver abscess patients who received prior metronidazole treatment Khairnar K Parija SC J Health Popul Nutr 16262027

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2334/8/131/prepub